Found 7 matching trials
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease II
PHASE3The primary objective of this study is to assess the long-term efficacy and...
Location
1222.14.5004 Boehringer Ingelheim Investigational Site
Effects of Mometasone Furoate/Formoterol Combination Versus Mometasone Furoate Alone in Persistent Asthmatics (Study P04073AM1)(COMPLETED)
PHASE3This is a randomized, multi-center, double-blind, double-dummy, placebo-con...
Location
Multiple Locations
Characterisation of 24-hour FEV1-time Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
PHASE3The study is intended to characterize the lung function profile of BI1744 i...
Location
1222.25.25009 Boehringer Ingelheim Investigational Site
Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I
PHASE3The primary objective of this study is to assess the long-term efficacy and...
Location
1222.13.2401 Boehringer Ingelheim Investigational Site
Characterization of 24 Hour Spirometry Profiles of Inhaled BI 1744 CL and Inhaled Foradil in Patients With Chronic Obstructive Pulmonary Disease
PHASE3The study is intended to characterize the lung function profile of BI1744 i...
Location
1222.24.24011 Boehringer Ingelheim Investigational Site
Efficacy and Safety Study to Compare Formoterol Fumerate in the Pressair DPI to the Foradil Aerolizer in Patient With Mild to Moderate Asthma
PHASE2The purpose of this Phase II study is to evaluate efficacy and safety of in...
Location
Forest Investigative Site 909
A Study of the Safety and Efficacy of 4 Doses of BI 1744 CL Delivered Via the Respimat in Patients With Asthma.
PHASE2The primary objective of this study is to determine the efficacy and safety...
Location
1222.27.43002 Boehringer Ingelheim Investigational Site